@prefix this: <http://purl.org/np/RA9OyVM1TNN2ZDi_LUrMXVSFt1meaS-3b1fdGgn68HuPQ> .
@prefix sub: <http://purl.org/np/RA9OyVM1TNN2ZDi_LUrMXVSFt1meaS-3b1fdGgn68HuPQ#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <https://uts.nlm.nih.gov/uts/umls/concept/> .
@prefix ns1: <http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
  
  sub:version prov:value "1"^^xsd:integer .
  
  rdf:object ns2:C0010340 "critically ill";
    ns2:C0030705 "patients";
    ns2:C0919747 "cytokine storm";
    ns2:C1280500 "effect";
    ns2:C1518681 "effect";
    ns2:C2348382 "effect";
    ns2:C5203670 "COVID-19" .
  
  rdf:predicate ns1:TRIPLE_UID:mapu4r1z-TRIPLE-ABSTRACT-2 "reduce" .
  
  rdf:subject ns2:C0001554 "administration";
    ns2:C0011777 "dexamethasone";
    ns2:C0021027 "immunoglobulin";
    ns2:C0021747 "interferon";
    ns2:C0202081 "immunoglobulin";
    ns2:C0205195 "combination";
    ns2:C0330390 "beta";
    ns2:C0439096 "beta";
    ns2:C0733470 "interferon";
    ns2:C1279919 "early";
    ns2:C1533734 "administration";
    ns2:C1552649 "beta";
    ns2:C1621846 "immunoglobulin";
    ns2:C1627258 "beta";
    ns2:C1947911 "combination";
    ns2:C2004068 "beta";
    ns2:C2348003 "administration";
    ns2:C3652465 "interferon";
    ns2:C3811910 "combination" .
  
  rdfs:Triple-UID ns3:TRIPLE_UID:mapu4r1z-TRIPLE-ABSTRACT-2 "mapu4r1z-TRIPLE-ABSTRACT-2" .
  
  rdfs:sentence rdfs:label "Therefore, we designed a trial to test we's hypothesis that early administration of dexamethasone in combination with immunoglobulin (IV)-IG) and interferon-beta can reduce the effect of the ensuing cytokine storm in critically ill patients COVID-19." .
  
  rdfs:triple rdfs:label "early administration of dexamethasone in combination with immunoglobulin ( IV)-IG ) and interferon - beta reduce the effect of the ensuing cytokine storm in critically ill patients COVID-19" .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-07-25T21:46:29.565844"^^xsd:dateTime .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "Ee467u4qv02TjFQusUNajo/lj0ow5VrVs44IThXNS6nwXMf0568ZkhnZAK1Ewfk1F95mZ3OwnGFjyII6PZEfaDLgee7mHH+VoDIx2jP5B90sIxiX+5oLW6GoMkhVOv0hm/rnyBQd8DJfg0FME8L5vYSEWFx7Iqf1HOKvtowO5po=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-07-25T21:46:29.565844"^^xsd:dateTime;
    prov:wasAttributedTo <https://orcid.org/0000-0002-8954-0470> .
}